Role of natural killer T cells in host defence against cryptococcal infection

Revista Iberoamericana de Micologia

Volumn 19, Issue 3, 2002, Pages 149-154

  Kawakami, Kazuyoshi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Cryptococcosis; Host defence; NKT cells

Indexed keywords

CD1 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1;

CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE RELEASE; HOST RESISTANCE; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; NATURAL KILLER CELL; REVIEW; T LYMPHOCYTE SUBPOPULATION;

EID: 0036755472     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Tateda K, Moore TA, Deng JC, et al. Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J Immunol 2001; 166: 3355-3361.
2. Pedrosa J, Saunders BM, Appleberg R, Orme IM, Silva MT, Cooper AM. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun 2000; 68: 577-583.
3. Horwitz DA, Gray JD, Ohtsuka K. Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease. Microbes Infect 1999; 1: 1305-1311.
4. Schaible UE, Kaufmann SH. CD1 molecules and CD1-dependent T cells in bacterial infections: A link from innate to acquired immunity? Semin Immunol 2000; 12: 527-535.
5. Nishimura T, Kitamura H, Iwakabe K, et al. The interface between innate and acquired immunity: Glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol 2000; 12: 987-994.
6. Taniguchi M, Nakayama T. Recognition and function of Vα14NKT cells. Semin Immunol 2000; 12: 543-550.
7. Godfrey DI, Hammond KJL, Poulton LD, Smyth MJ, Baxter AG. NKT cells: Facts, functions and fallacies. Immunol Today 2000; 21: 573-583.
8. Joyce S, Woods AS, Yewdell JW, et al. Natural ligand of mouse CD1d: Cellular glycosylphosphatidyl-inositol. Science 1998; 279: 1541-1544.
9. Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997; 278: 1626-1629.
10. Burdin N, Brossay L, Koezuka Y, et al. Selective ability of mouse CD1 to present glycolipids: α-galactosylceramide specifically stimulates Vα14 NK T lymphocytes. J Immunol 1998; 161: 3271-3281.
11. Kitamura H, Iwakabe K, Yahata T, et al. The natural killer T (NKT) cell ligand αgalactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 1999; 189: 1121-1128.
12. Cui J, Watanabe N, Kawano T, et al. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer cells. J Exp Med 1999; 190: 783-792.
13. Burdin N, Brossay L, Kronenberg M: Immunization with α-galactosylceramide polarizes CD1-reactive NKT cells towards Th2 cytokine synthesis. Eur J Immunol 1999; 29: 2014-2025.
14. Singh N, Hong S, Scherer DC, et al. Activation of NK T cells by CD1d and αgalactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 1999; 163: 2373-2377.
15. Hayakawa Y, Takeda K, Yagita H, van Kaer L, Saiki I, Okumura K. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J Immunol 2001; 166: 6012-6018.
16. Cui J, Shin T, Kawano T, et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278: 1623-1626.
17. Kawano T, Cui J, Koezuka Y, et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc Natl Acad Sci USA 1998; 95: 5690-5693.
18. Takeda K, Seki S, Ogasawara K, et al. Liver NK1.1+CD4+ αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J Immunol 1996; 156: 3366-3373, 1996.
19. Toura I, Kawano T, Akutsu Y, Nakayama T, Ochiai T, Taniguchi M. Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. J Immunol 1999; 163: 2387-2391.
20. Gombert JM, Herbelin A, Trancrede-Bohin E, Dy M, Carnaud C, Bach JF. Early quantitative and functional deficiency of NK1+ like thymocytes in the NOD mouse. Eur J Immunol 1996; 26: 2989-2998.
21. Hammond KJ, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG. α/β-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabe c1labetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 1998; 187: 1047-1056.
22. Mieza MA, Itoh T, Cui JQ, et al. Selective reduction of Vα14+ NK T cells associated with disease development in autoimmuneprone mice. J Immunol 1996; 156: 4035-4040.
23. Wilson SB, Kent SC, Patton KT, et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type-1 diabetes. Nature 1998; 391: 177-181.
24. Yoshimoto T, Bendelac A, Watson C, HuLi J, Paul WE. Role of NK1.1+T cells in a TH2-response and in immunoglobulin E production. Science 1995; 270: 1845-1847.
25. Brown DR, Fowell DJ, Corry DB, et al. β2-microglobulin-dependent NK1.1+T cells are not essential for T helper cell 2 immune responses. J Exp Med 1996; 184: 1295-1304.
26. Chen Y-H, Chiu NM, Mandal M, Wang N, Wang CR. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 1997; 6: 459-467.
27. Smiley ST, Kaplan MH, Grusby MJ. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 1997; 275: 977-979.
28. Zhang Y, Rogers KH, Lewis DB. β2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J Exp Med 1996; 184: 1507-1512.
29. Bendelac A, Hunziker RD, Lantz O. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J Exp Med 1996; 184: 1285-1293.
30. Carnaud C, Lee D, Donnars O, et al. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 1999; 163: 4647-4650.
31. Apostolou I, Takahama Y, Belmant C, et al. Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci USA 1999; 96: 5141-5146.
32. Gonzalez-Aseguinolaza G, de Oliveira C, Tomsaka M, et al. α-galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci USA 2000; 97: 8461-8466.
33. Behar SM, Dascher CC, Grusby MJ, Wang C-R, Brenner MB. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 1999; 189: 1973-1980.
34. Sousa AO, Mazzaccaro RJ, Russell RG, et al. Relative contributions of distinct MHC class 1-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci USA 2000; 97: 4204-4208.
35. Szalay G, Zugel U, Ladel CH, Kaufmann SHE. Participation of group 2 CD1 molecules in the control of murine tuberculosis. Microb Infect 1999; 1: 1153-1157.
36. Kawakami K, Kinjo Y, Uezu K, et al. Minimal contribution of Vα14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol Immunol 2002; 46: 207-210.
37. Ishigami M, Nishimura H, Naiki Y, et al. The roles of intrahepatic Vα14+ NK1.1+ T cells for liver injury induced by Salmonella infection in mice. Hepatology 1999; 29: 1799-1808.
38. Szalay G, Ladel CH, Blum C, Brossay L, Kronenberg M, Kaufmann SHE. Anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-β2 and Th1 cytokines and ameliorates listeriosis in mice. J Immunol 1999; 162: 6955-6958.
39. Nakano Y, Hisaeda H, Sakai T, et al. Role of innate immune cells in protection against Toxoplasma gondii at inflamed site. J Med Invest 2001; 48: 73-80.
40. Ishikawa H, Hisaeda H, Taniguchi M, et al. CD4+ Vα14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int Immunol 2000; 12: 1267-1274.
41. Duthie MS, Wleklinski-Lee M, Smith S, Nakayama T, Taniguchi M, Kahn SJ. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinostol-modified surface protein. Infect Immun 2002; 70: 36-48.
42. Kumar H, Belperron A, Barthold SW, Bockenstedt LK. CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol 2000; 165: 4797-4801.
43. - subsets of intermediate TCR cells which are constituents of innate immunity. Cell Immunol 2001; 211: 96-104.
44. Um TS, Murphy JW. Transfer of immunity,to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans sensitized mice. Infect Immun 1980; 30: 5-11.
45. Huffnagle GB, Yates JL, Lipscomb MF. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J Exp Med 1991; 173: 793-800.
46. Hill JO, Harmsen AG. Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells. J Exp Med 1991; 173: 755-758.
47. Kawakami K, Tohyama M, Xie Q, Saito A. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: Effects of interleukin-12. Infect Immun 1997; 65: 1307-1312.
48. Koguchi Y, Kawakami K. Cryptococcal infection and Th1-Th2 cytokine balance. Int Rev Immunol 2002 (in press).
49. Kawakami K, Koguchi Y, Qureshi MH, et al. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. J Immunol 2000; 165: 941-947.
50. Rayhane N, Lortholary O, Fitting C, et al. Enhanced sensitivity of tumor necrosis factor/lymphotoxin-alpha-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-gamma, and interleukin-12. J Infect Dis 1999; 180: 1637-1647.
51. Decken K, Kohler G, Palmer-Lehmann K, et al. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun 1998; 66: 4994-5000.
52. Blackstock R, Buchanan KL, Adesina AM, Murphy JW. Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect Immun 1999; 67, 3601-3609.
53. Robinson D, Shibuya K, Mui A, et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-g production and activates IRAK and NFkB. Immunity. 1997; 7: 571-581.
54. Kawakami K, Kinjo Y, Uezu K, et al. Monocyte chemoattractant protein-1dependent increase of Vα14NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J Immunol 2001; 167: 6525-6532.
55. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000; 217: 217-242.
56. Maghazachi AA, Skalhegg BS, Rolstad B, Al-Aoukaty A. Interferon-inducible protei-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins. FASEB J 1997; 11: 765-774.
57. Taub DD, Sayers TJ, Carter CR, Ortaldo JR. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995; 155: 3877-3888.
58. Allavena P, Bianchi G, Zhou D, et al. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and 3. Eur J Immunol 1994; 24: 3233-3236.
59. Maghazachi AA, Al-Aoukaty A, Schall TJ. C-C chemokine induce the chemotaxis of NK and IL-2-activated NK cells. Role for G-proteins. J Immunol 1994; 153: 4969-4977.
60. 2+ mobilization, and enzyme release. J Immunol 1996; 156: 322-327.
61. Giancarlo B, Silvano S, Albert Z, Mantovani A, Allavena P. Migratory response of human natural killer cells to lymphotactin. Eur J Immunol 1996; 26: 3238-3241.
62. Faunce DE, Sonoda K, Stein-Streilein J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J Immunol 2001; 166: 313-321.
63. Liu CC, Perussia B, Young JD. The emerging role of IL-15 in NK-cell development. Immunol Today 2000; 21: 113-116.
64. Schofield L, McConville MJ, Hansen D, et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999; 283: 225-229.
65. Molano A, Park SH, Chiu YH, Nosseir S, Bendelac A, Tsuji M. Cutting edge: The IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: Exploring the role of GPIs in NK T cell activation and antimalarial responses. J Immunol 2000; 164: 5005-5009.
66. Franzot SP, Doering TL. Inositol acylation of glycosylphosphatidylinositols in the pathogenic fungus Cryptococcus neoformans and the model yeast Saccharomyces cerevisiae. Biochem J 1999; 340: 25-32.
67. Gonzalez-Asequinolaza G, van Kaer L, Bergmann CC, et al. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J Exp Med 2002; 195: 617-624.
68. Levitz SM, Nong S, Mansour MK, Huang C, Specht CA. Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proc Natl Acad Sci USA 2001; 98: 10422-10427.
69. Kawakami K, Kinjo Y, Yara S, et al. Activation of Vα14+ natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect Immunol 2001; 69: 213-220.
70. Kawakami K, Kinjo Y, Yara S, et al. Enhanced gamma interferon production through activation of Vα14+ natural killer T cells by α-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis. Infect Immun 2001; 69: 6643-6650.
71. Nieuwenhuis EE, Matsumoto T, Exley M, et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 2002; 8: 588-593.